Predicting Chest Wall Pain From Lung Stereotactic Body Radiotherapy for Different Fractionation Schemes

被引:43
|
作者
Woody, Neil M. [1 ]
Videtic, Gregory M. M. [1 ]
Stephans, Kevin L. [1 ]
Djemil, Toufik [1 ]
Kim, Yongbok [2 ]
Xia, Ping [1 ]
机构
[1] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Ctr, Cleveland, OH 44195 USA
[2] Allegheny Gen Hosp, Dept Radiat Oncol, Pittsburgh, PA 15212 USA
关键词
Stereotactic body radiation therapy; Chest wall pain; Modified effective uniform dose; Stage I lung cancer; Radiobiologic effect; RADIATION-THERAPY; CANCER; TRIAL;
D O I
10.1016/j.ijrobp.2011.06.1971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Recent studies with two fractionation schemes predicted that the volume of chest wall receiving >30 Gy (V30) correlated with chest wall pain after stereotactic body radiation therapy (SBRT) to the lung. This study developed a predictive model of chest wall pain incorporating radiobiologic effects, using clinical data from four distinct SBRT fractionation schemes. Methods and Materials: 102 SBRT patients were treated with four different fractionations: 60 Gy in three fractions, 50 Gy in five fractions, 48 Gy in four fractions, and 50 Gy in 10 fractions. To account for radiobiologic effects, a modified equivalent uniform dose (mEUD) model calculated the dose to the chest wall with volume weighting. For comparison, V30 and maximum point dose were also reported. Using univariable logistic regression, the association of radiation dose and clinical variables with chest wall pain was assessed by uncertainty coefficient (U) and C statistic (C) of receiver operator curve. The significant associations from the univariable model were verified with a multivariable model. Results: 106 lesions in 102 patients with a mean age of 72 were included, with a mean of 25.5 (range, 12-55) months of follow-up. Twenty patients reported chest wall pain at a mean time of 8.1 (95% confidence interval, 6.3-9.8) months after treatment. The mEUD models, V30, and maximum point dose were significant predictors of chest wall pain (p < 0.0005). mEUD improved prediction of chest wall pain compared with V30 (C = 0.79 vs. 0.77 and U = 0.16 vs. 0.11). The mEUD with moderate weighting (a = 5) better predicted chest wall pain than did mEUD without weighting (a = 1) (C = 0.79 vs. 0.77 and U = 0.16 vs. 0.14). Body mass index (BMI) was significantly associated with chest wall pain (p = 0.008). On multivariable analysis, mEUD and BMI remained significant predictors of chest wall pain (p = 0.0003 and 0.03, respectively). Conclusion: mEUD with moderate weighting better predicted chest wall pain than did V30, indicating that a small chest wall volume receiving a high radiation dose is responsible for chest wall pain. Independently of dose to the chest wall, BMI also correlated with chest wall pain. (C) 2012 Elsevier Inc.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 50 条
  • [41] Stereotactic Ablative Body Radiotherapy for Lung Cancer
    Franks, K. N.
    Jain, P.
    Snee, M. P.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 280 - 289
  • [42] Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial
    Lau, Brianna
    Wu, Yufan F.
    Cui, Sunan
    Fu, Jie
    Jackson, Scott
    Pham, Daniel
    Dubrowski, Piotr
    Eswarappa, Shaila
    Skinner, Lawrie
    Shirato, Hiroki
    Taguchi, Hiroshi
    Gensheimer, Michael F.
    Gee, Harriet
    Chin, Alexander L.
    Diehn, Maximilian
    Loo, Billy W.
    Moiseenko, Vitali
    Vitzthum, Lucas K.
    RADIOTHERAPY AND ONCOLOGY, 2024, 196
  • [43] Stereotactic body radiotherapy for central lung tumours
    Dahele, M.
    Tekatli, H.
    Senan, S.
    BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1053):
  • [44] Lung reirradiation with stereotactic body radiotherapy (SBRT)
    Ester, Elizabeth C.
    Jones, Daniel A.
    Vernon, Matthew R.
    Yuan, Jianling
    Weaver, Randi D.
    Shanley, Ryan M.
    Andrade, Rafael S.
    Cho, L. Chinsoo
    JOURNAL OF RADIOSURGERY AND SBRT, 2013, 3 (04): : 325 - 331
  • [45] Stereotactic body radiotherapy in lung cancer: an update
    Cintra Vita Abreu, Carlos Eduardo
    Rodrigues Ferreira, Paula Pratti
    de Moraes, Fabio Ynoe
    Pimenta Neves, Wellington Furtado, Jr.
    Gadia, Rafael
    Carvalho, Heloisa de Andrade
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2015, 41 (04) : 376 - 387
  • [46] Stereotactic Body Radiotherapy for Malignant Nodules in the Lung
    Nestle, U.
    Guckenberger, M.
    ZENTRALBLATT FUR CHIRURGIE, 2013, 138 : S25 - S31
  • [47] Stereotactic Body Radiotherapy for Central Lung Tumors
    Rowe, Bryan P.
    Boffa, Daniel J.
    Wilson, Lynn D.
    Kim, Anthony W.
    Detterbeck, Frank C.
    Decker, Roy H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1394 - 1399
  • [48] CHEST WALL TOXICITY FOLLOWING RISK-ADAPTED STEREOTACTIC RADIOTHERAPY FOR EARLY STAGE LUNG CANCER
    Bongers, Eva Marrit
    Haasbeek, Cornelis J.
    Lagerwaard, Frank J.
    Slotman, Ben
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S277 - S277
  • [49] Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer
    Pasqualetti, Francesco
    Montrone, Sabrina
    Vivaldi, Caterina
    Zani, Margherita
    Fedele, David
    Fornaro, Lorenzo
    Pasqualetti, Giuseppe
    Salvatore, Lisa
    Manfredi, Bruno
    Laliscia, Concetta
    Coraggio, Gabriele
    Gonnelli, Alessandra
    Loupakis, Fotios
    Masi, Gianluca
    Sainato, Aldo
    Monzani, Fabio
    Falcone, Alfredo
    Paiar, Fabiola
    ANTICANCER RESEARCH, 2017, 37 (01) : 315 - 319
  • [50] A Novel Nomogram for Predicting Distant Metastases after Lung Stereotactic Body Radiotherapy for Early Stage Lung Cancer
    Oh, Steven C.
    Chagin, Kevin
    Woody, Neil
    Ward, Matthew
    Pham, Yvonne
    Kittel, Jeffrey
    Videtic, Gregory M. M.
    Stephans, Kevin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S211 - S211